158 related articles for article (PubMed ID: 16918130)
1. Transplatin, a cisplatin trans-isomer, may enhance the anticancer effect of 5-fluorouracil.
Nakata B; Yamagata S; Kanehara I; Shirasaka T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):195-200. PubMed ID: 16918130
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
Tanaka T; Masuda H; Naito M; Tamai H
Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
[TBL] [Abstract][Full Text] [Related]
4. In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: timing of cisplatin treatment.
Cho H; Imada T; Oshima T; Shiozawa M; Rino Y; Takanashi Y
Gastric Cancer; 2002; 5(1):43-6. PubMed ID: 12021859
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y
Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism for synergistic antitumor effect in the combination of 5-fluorouracil with cisplatin in vivo tumor models: from the view of biochemical modulation of 5-fluorouracil].
Shirasaka T; Shimamoto Y; Ohshimo H; Kimura A; Fukushima M
Gan To Kagaku Ryoho; 1991 Mar; 18(3):403-9. PubMed ID: 2003740
[TBL] [Abstract][Full Text] [Related]
7. Prediction of 5-fluorouracil and cisplatin synergism for advanced gastrointestinal cancers using a collagen gel droplet embedded culture.
Mori S; Kunieda K; Sugiyama Y; Saji S
Surg Today; 2003; 33(8):577-83. PubMed ID: 12884094
[TBL] [Abstract][Full Text] [Related]
8. Etoposide enhances the antitumor effects of cisplatin in gastric cancer cells.
Hotta T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tsunoda T; Noguchi K; Mizobata S; Arii K; Terasawa H
Anticancer Res; 1997; 17(2A):885-9. PubMed ID: 9137422
[TBL] [Abstract][Full Text] [Related]
9. Schedule-dependent reversion of cisplatin resistance by 5-fluorouracil in a cisplatin-resistant human lung adenocarcinoma cell line A549DDP.
Zhan M; Liu X
Chin Med J (Engl); 1999 Apr; 112(4):336-9. PubMed ID: 11593534
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
Okamura M; Shimada J; Sakagami H
Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
[TBL] [Abstract][Full Text] [Related]
11. Does cisplatin (CDDP) function as a modulator of 5-fluorouracil (5-FU) antitumor action? A study based on a clinical trial.
Matsusaka S; Nagareda T; Yamasaki H
Cancer Chemother Pharmacol; 2005 Apr; 55(4):387-392. PubMed ID: 15647947
[TBL] [Abstract][Full Text] [Related]
12. [Comparison between leucovorin and cisplatin as a modulator of 5-fluorouracil].
Iba T; Yagi Y; Kidokoro A; Fukunaga T
Gan To Kagaku Ryoho; 1993 Mar; 20(4):479-83. PubMed ID: 8452385
[TBL] [Abstract][Full Text] [Related]
13. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.
Tsai CM; Hsiao SH; Frey CM; Chang KT; Perng RP; Gazdar AF; Kramer BS
Cancer Res; 1993 Mar; 53(5):1079-84. PubMed ID: 8382553
[TBL] [Abstract][Full Text] [Related]
14. [Fundamental study of combination chemotherapy with THP, 5-FU and CDDP for human KB carcinoma cell line and its multidrug resistant cell line KB-C1--usefulness of treatment with 5-FU preceding CDDP].
Kishimoto H; Manno Y; Tanaka H; Moridera K; Urade M
Gan To Kagaku Ryoho; 2001 Apr; 28(4):505-9. PubMed ID: 11329785
[TBL] [Abstract][Full Text] [Related]
15. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor.
Nakagawa M; Yamaguchi T; Fukawa H; Ogata J; Komiyama S; Akiyama S; Kuwano M
Jpn J Cancer Res; 1985 Apr; 76(4):315-20. PubMed ID: 2408954
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
[TBL] [Abstract][Full Text] [Related]
17. The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line.
Johnston PG; Geoffrey F; Drake J; Voeller D; Grem JL; Allegra CJ
Eur J Cancer; 1996 Nov; 32A(12):2148-54. PubMed ID: 9014759
[TBL] [Abstract][Full Text] [Related]
18. [The influence of sodium thiosulfate on the antitumor effect of cisplatin in human gastric cancer cell lines].
Fujii T; Saito D; Yoshida S; Ookura H; Oguro Y
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3227-32. PubMed ID: 3196041
[TBL] [Abstract][Full Text] [Related]
19. [Changes in folate levels after cisplatin treatment of gastric cancer].
Iba T; Yagi Y; Kidokoro A; Ishi K; Koyatsu J
Gan To Kagaku Ryoho; 1996 Apr; 23(5):573-7. PubMed ID: 8678515
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a cisplatin-resistant gastric carcinoma cell line OCUM-2M/DDP.
Nitta A; Chung YS; Nakata B; Yashiro M; Onoda N; Maeda K; Sawada T; Sowa M
Cancer Chemother Pharmacol; 1997; 40(1):94-7. PubMed ID: 9137537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
